Title: Chairman and CEO
Company: Emergent BioSolutions
Industry: Biotechnology
Category: Public Companies
2007 Compensation Details
| Total Compensation | $868,010 |
| Salary | $509,100 |
skip to main |
skip to sidebar
Followers
Blog Archive
-
▼
2009
(23)
-
▼
August
(17)
- Fuad El-Hibri on Yale Healthcare 2009 Advisory Board
- 2007 Executive Compensation Report
- Emergent BioSolutions Inc., Q2 2009 Earnings Call ...
- Emergent BioSolutions Inc. (EBS) CEO & Chairman, 1...
- Emergent Biosolutions Announces That Biothrax (Ant...
- Rene Moawad Foundation (RMF-USA) 14th Annual Washi...
- Emergent looks to buy Maryland lab
- Fuad El-Hibri Chairman of the Board of Directors a...
- Fuad El-Hibri on FunnyOrDie
- Maker of anthrax vaccine discusses challenges of m...
- Fuad El-Hibri on lead411
- Fuad El-Hibri on Dailymotion
- Emergent BioSolutions Inc. Company Profile
- EMERGENT BIOSOLUTIONS’ TYPHOID VACCINE CANDIDATE A...
- Fuad El-Hibri on CorridorInc
- Severance and Termination Protection Program
- Fuas El-Hibri on Xanga
-
▼
August
(17)
Labels
- : Business (1)
- Abdul Aziz Said (1)
- academic (1)
- Activism and Peace Work (1)
- Aeras Global TB Foundation (1)
- American Society of Hematology (2)
- Anthrax (3)
- anthrax vaccine (1)
- Anthrax vaccines (17)
- Arab world (1)
- Atlanta (1)
- award (3)
- B-cell chronic lymphocytic leukemia (1)
- Baltimore (1)
- BARDA (1)
- Bendamustine (1)
- biopharmaceutical (2)
- biopharmaceutical company (1)
- Biosolutions (1)
- BioSolutions Inc (1)
- Biotech (1)
- Biotech CEO of the Year (1)
- Biotechnology (1)
- Biotechnology and Pharmaceuticals (3)
- Biothrax (7)
- BIOTHRAX® (2)
- Board of directors (5)
- Business (14)
- Business Power 500 (1)
- businessman (1)
- california (1)
- Centers for Disease Control and Prevention (1)
- Central America (1)
- CEO (1)
- Chairman (5)
- Chairman of the Board (3)
- Chairman of the Board of Directors (2)
- chief executive office (4)
- Chief Executive Officer (26)
- Chief financial officer (2)
- Chief operating officer (1)
- Clinical trial (4)
- colleagues (1)
- Colman McCarthy (1)
- Common stock (1)
- Conference call (2)
- Crisis (1)
- Dailymotion (1)
- Daniel Heifetz (1)
- DEPARTMENT OF HEALTH AND HUMAN SERVICES (1)
- Dr. Mary Elizabeth King (1)
- El Hibri Charitable Foundation (1)
- el-hibri (1)
- El-Hibri Peace Education Prize (4)
- Emergent (1)
- Emergent BioSolutions (53)
- Emergent Biosolutions Inc (3)
- Employment (1)
- entrepreneur (3)
- Ernst Young (1)
- European Parliament (1)
- Executive Profile (2)
- Federal government of the United States (2)
- finance (3)
- Financial Results (1)
- Food and Drug Administration (14)
- fuad (5)
- fuad el-hibri (42)
- FunnyOrDie (1)
- Gene Sharp (1)
- Global Healthcare Conference (1)
- Harvard University (1)
- Health (2)
- Health care (1)
- Healthcare Conference (2)
- Heifetz International Music Institute (1)
- Hematology (1)
- Honors (1)
- Hosni Mubarak (1)
- Hudson Institute (1)
- Human rights (1)
- Humanitarian aid (3)
- Infectious disease (7)
- Insurance (1)
- International Biomedical Research Alliance (1)
- Investor relations (1)
- Investors (3)
- Jascha Brodsky (1)
- Kennedy (1)
- Kofi Annan (1)
- Leadership (1)
- Lebanese (3)
- Lebanon (2)
- Leukemia (1)
- Leukemia and Lymphoma Society (1)
- Life Sciences Conference (1)
- Lymphocyte (1)
- Lymphoma (1)
- Management (1)
- Marketing (3)
- Martin O'Malley (1)
- Maryland (3)
- Maryland f (2)
- Master of Business Administration (3)
- Mauro Gibellini (1)
- Medical research (1)
- Middle East (3)
- Minister of Social Affairs (1)
- muslims (1)
- Nancy Ajram (1)
- National Cancer Institute (1)
- National Health Museum (1)
- National Institute of Allergy and Infectious Diseases (2)
- National Institutes of Health (2)
- NATO (2)
- Nayla Moawad (1)
- Needham and Company Healthcare Conference (1)
- New York Stock Exchange (2)
- Nobel Peace Prize (1)
- Non-Hodgkin lymphoma (2)
- Non-profit organization (2)
- North Atlantic Treaty Organization (1)
- Oxford University (1)
- peace (2)
- Pharmaceutical (1)
- Pharmaceuticals (1)
- Philanthropy (1)
- president (1)
- Profile (1)
- Public health (1)
- Real estate (1)
- Research and development (3)
- Research Scholars (1)
- Risk management (1)
- Ritz-Carlton (1)
- Rockville (2)
- Rockville Maryland (1)
- rPA vaccines (1)
- S.C. Johnson Graduate School of Management (1)
- Santa Cruz (1)
- Scholars Program (1)
- Seattle (2)
- Singapore Ministry of Health (1)
- Social Media (1)
- Society and Culture (1)
- South Africa (1)
- South African Tuberculosis Vaccine (1)
- Stanford University (1)
- stock (3)
- Strategic National Stockpile (2)
- Systemic Lupus Erythematosus (1)
- Takreem Achievement Awards (1)
- TB Vaccine (2)
- Tech Council of Maryland (1)
- Technology (1)
- Toronto Stock Exchange (1)
- Trubion Pharmaceuticals (2)
- Tuberculosis (3)
- Tuberculosis Consortium Vaccinates (1)
- U.S. Food and Drug Administration (4)
- U.S. government (2)
- United States (14)
- United States Chamber of Commerce (1)
- United States Department of Defense (1)
- United States Department of Health and Human Services (2)
- United States. (1)
- University of Oxford (1)
- US (1)
- US government (1)
- Vaccination (1)
- Vaccine (1)
- Vice president (1)
- vilcek (1)
- vileck foundation (1)
- Wael Ghonim (1)
- Washington (1)
- Washington Post (1)
- Webcast (3)
- Website (1)
- World Health Organization (1)
- Yale (1)
- Yale School of Management (1)
- Yale University (3)
About Me
- Fuad El-Hibri
- Fuad El-Hibri, Chief Executive Officer and Chairman of the Board of Directors. Mr. El-Hibri has served as chief executive officer and chairman of the board of directors since June 2004 and as president from March 2006 to April 2007. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a result of our corporate reorganization, BioPort became a wholly owned subsidiary of Emergent.